Omega Healthcare price target raised to $33 from $32 at Scotiabank

Scotiabank raised the firm’s price target on Omega Healthcare to $33 from $32 and keeps a Sector Perform rating on the shares. Midtown New York City has been a more active office market than others in the analyst’s coverage and the firm expects continued leasing progress will support valuation and sentiment on the stock, the analyst tells investors. The firm adjusted its estimates to reflect recent operating and capital allocation updates.